Antibacterial Agents

Maker cites Retroscreen Virology study that shows hand sanitizer effective against bird flu

Published in Hepatitis Weekly, February 20th, 2006

Skinvisible, Inc. (SKVI) announced that a study by Retroscreen Virology of Skinvisible's patent-pending chlorhexidine hand sanitizer, developed by its wholly owned subsidiary Skinvisible Pharmaceuticals, had a greater than 99% kill on the bird flu virus (H5N1) at four time points of 15 seconds, 30 seconds, 1 minute and 5 minutes.

In vitro studies demonstrate a sustained release of the active ingredient over a 6-hour period. The study results were reported by Skinvisible at the Retroscreen Virology conference, "Bird Flu: The First Pandemic of the 21st Century," at St. Bartholomew's Hospital, London.

The active ingredient in Skinvisible's product is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2006-02-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry